Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Noncommunicable diseases associated with hemorrhagic disorders, hospitalization and mortality in patients with dengue in Mexico: a national analysis of confirmed cases in 2024

Diego Rolando Hernández Galdamez, Miguel Ángel González-Block, Daniela Karola Romo-Dueñas, View ORCID ProfileErick Antonio Osorio López, Rosalba Cerón-Meza, Pablo Méndez-Hernández
doi: https://doi.org/10.1101/2025.02.24.25322761
Diego Rolando Hernández Galdamez
1Escuela de Salud Pública de México, Cuernavaca, Morelos, México
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Miguel Ángel González-Block
2Universidad Anáhuac, Ciudad de México, México
3Instituto Nacional de Salud Pública, Cuernavaca, Morelos, México
4Evisys Consulting, Ciudad de México, México
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniela Karola Romo-Dueñas
1Escuela de Salud Pública de México, Cuernavaca, Morelos, México
5Centro de Estudios en Salud, Universidad del Valle de Guatemala, Ciudad de Guatemala, Guatemala
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Erick Antonio Osorio López
1Escuela de Salud Pública de México, Cuernavaca, Morelos, México
6Facultad de Medicina, Universidad Nacional Autónoma de México, Ciudad de México, México
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Erick Antonio Osorio López
  • For correspondence: erickosoriolopez{at}comunidad.unam.mx
Rosalba Cerón-Meza
7Facultad de Agrobiología, Universidad Autónoma de Tlaxcala, Tlaxcala, México
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pablo Méndez-Hernández
7Facultad de Agrobiología, Universidad Autónoma de Tlaxcala, Tlaxcala, México
8Hospital General de Tlaxcala, Secretaría de Salud de Tlaxcala, Tlaxcala, México
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background In Mexico, some of the most prevalent non-communicable diseases (NCDs) among adults are diabetes, hypertension, and chronic kidney disease (CKD). Mexico could be going through a syndemic of dengue and NCDs. This study aims to describe and analyze the association between the prevalence of NCDs and hospitalization, the presence of hemorrhagic disorders, and death in all officially confirmed cases of dengue in Mexico during 2024.

Methodology/Principal Findings This cross-sectional study is carried out through a secondary analysis of the confirmed cases of dengue reported in 2024. The likelihood of hospitalization, hemorrhagic disorders, and death were assessed according to NCDs, estimating odds ratios (ORs). A multivariate logistic regression model was used, adjusting by age, sex, and for each of the NCDs (diabetes, hypertension, chronic kidney disease, immunosuppression, cirrhosis, and peptic ulcer disease). The most co-prevalent non-communicable diseases were diabetes, hypertension, CKD, and immunosuppression. For hospitalization, CKD has the highest risk of hospitalization (OR 5.73), followed by immunosuppression (OR 2.84), peptic ulcer disease (OR 2.35), and diabetes (OR 2.09). We found higher probabilities for having bleeding disorders in people with diabetes (OR 19.51), peptic ulcer disease (OR 7.85), immunosuppression (OR 4.75), cirrhosis (OR 3.37), and hypertension (OR 2.99) compared to people who did not have these diseases. The highest risk for death was observed in the cases with CKD (OR 6.54), followed by peptic ulcer disease (OR 3.09) and diabetes (OR 2.87).

Conclusions/Significance Patients with dengue and some comorbidities were more likely to have worse clinical outcomes, such as being hospitalized, having bleeding disorders, or dying. The syndemic of NCDs and dengue in Mexico has been rapidly increasing, and this problem needs to be addressed. This work demonstrates that patients with these comorbidities have worse clinical outcomes.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

The author(s) received no specific funding for this work.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Expemption is granted because this is a study based on secondary data sources.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Data Availability

All relevant data are within the manuscript and its Supporting Information files.

https://www.gob.mx/cms/uploads/attachment/file/965318/Datos_abiertos_historicos_etv_2024.pdf

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted February 25, 2025.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Noncommunicable diseases associated with hemorrhagic disorders, hospitalization and mortality in patients with dengue in Mexico: a national analysis of confirmed cases in 2024
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Noncommunicable diseases associated with hemorrhagic disorders, hospitalization and mortality in patients with dengue in Mexico: a national analysis of confirmed cases in 2024
Diego Rolando Hernández Galdamez, Miguel Ángel González-Block, Daniela Karola Romo-Dueñas, Erick Antonio Osorio López, Rosalba Cerón-Meza, Pablo Méndez-Hernández
medRxiv 2025.02.24.25322761; doi: https://doi.org/10.1101/2025.02.24.25322761
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Noncommunicable diseases associated with hemorrhagic disorders, hospitalization and mortality in patients with dengue in Mexico: a national analysis of confirmed cases in 2024
Diego Rolando Hernández Galdamez, Miguel Ángel González-Block, Daniela Karola Romo-Dueñas, Erick Antonio Osorio López, Rosalba Cerón-Meza, Pablo Méndez-Hernández
medRxiv 2025.02.24.25322761; doi: https://doi.org/10.1101/2025.02.24.25322761

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (434)
  • Allergy and Immunology (760)
  • Anesthesia (222)
  • Cardiovascular Medicine (3316)
  • Dentistry and Oral Medicine (366)
  • Dermatology (282)
  • Emergency Medicine (480)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1175)
  • Epidemiology (13403)
  • Forensic Medicine (19)
  • Gastroenterology (900)
  • Genetic and Genomic Medicine (5182)
  • Geriatric Medicine (483)
  • Health Economics (786)
  • Health Informatics (3286)
  • Health Policy (1146)
  • Health Systems and Quality Improvement (1199)
  • Hematology (432)
  • HIV/AIDS (1024)
  • Infectious Diseases (except HIV/AIDS) (14657)
  • Intensive Care and Critical Care Medicine (917)
  • Medical Education (478)
  • Medical Ethics (128)
  • Nephrology (526)
  • Neurology (4957)
  • Nursing (263)
  • Nutrition (735)
  • Obstetrics and Gynecology (889)
  • Occupational and Environmental Health (797)
  • Oncology (2531)
  • Ophthalmology (730)
  • Orthopedics (284)
  • Otolaryngology (348)
  • Pain Medicine (323)
  • Palliative Medicine (90)
  • Pathology (547)
  • Pediatrics (1308)
  • Pharmacology and Therapeutics (552)
  • Primary Care Research (559)
  • Psychiatry and Clinical Psychology (4225)
  • Public and Global Health (7526)
  • Radiology and Imaging (1717)
  • Rehabilitation Medicine and Physical Therapy (1022)
  • Respiratory Medicine (982)
  • Rheumatology (480)
  • Sexual and Reproductive Health (500)
  • Sports Medicine (425)
  • Surgery (551)
  • Toxicology (73)
  • Transplantation (237)
  • Urology (206)